Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors

BACKGROUND: Streptozocin (STZ) based chemotherapy is recommended for patients with metastatic pancreatic neuroendocrine tumors (pNET). Temozolomide as mono- or combination therapy has been suggested to be a promising alternative. However, the treatment is costly and not approved for the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mueller, Daniela, Krug, Sebastian, Majumder, Moushumee, Rinke, Anja, Gress, Thomas Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989525/
https://www.ncbi.nlm.nih.gov/pubmed/27538897
http://dx.doi.org/10.1186/s12885-016-2642-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989525/
https://www.ncbi.nlm.nih.gov/pubmed/27538897
http://dx.doi.org/10.1186/s12885-016-2642-1

Ejemplares similares